These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3321307)
21. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes. Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784 [TBL] [Abstract][Full Text] [Related]
22. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event. Hansen LA; Spalding JW; French JE; Tennant RW Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720 [TBL] [Abstract][Full Text] [Related]
23. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892 [TBL] [Abstract][Full Text] [Related]
25. Neoplastic transformation of human cells in vitro. Rhim JS Crit Rev Oncog; 1993; 4(3):313-35. PubMed ID: 8485202 [TBL] [Abstract][Full Text] [Related]
26. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization. Agarwal R; Mohan RR; Ahmad N; Mukhtar H Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous chemical carcinogenesis. Yuspa SH J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1031-44. PubMed ID: 3537025 [TBL] [Abstract][Full Text] [Related]
28. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982 [TBL] [Abstract][Full Text] [Related]
29. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416 [TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
31. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations]. Tubiana M Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515 [TBL] [Abstract][Full Text] [Related]
32. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways. Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183 [TBL] [Abstract][Full Text] [Related]
33. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Katiyar SK; Agarwal R; Mukhtar H Cancer Res; 1993 Nov; 53(22):5409-12. PubMed ID: 8221679 [TBL] [Abstract][Full Text] [Related]
34. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene. Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726 [TBL] [Abstract][Full Text] [Related]
35. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302 [TBL] [Abstract][Full Text] [Related]
37. Cell culture studies on the mechanism of action of chemical carcinogens and tumor promoters. Weinstein IB Carcinog Compr Surv; 1985; 10():177-87. PubMed ID: 4064003 [TBL] [Abstract][Full Text] [Related]
38. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
39. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981 [TBL] [Abstract][Full Text] [Related]
40. Chemical carcinogenesis: from animal models to molecular models in one decade. Yuspa SH; Poirier MC Adv Cancer Res; 1988; 50():25-70. PubMed ID: 3287845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]